Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence.
about
Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Tobramycin inhalation powder f ...... ew based on clinical evidence.
@en
Tobramycin inhalation powder f ...... ew based on clinical evidence.
@nl
type
label
Tobramycin inhalation powder f ...... ew based on clinical evidence.
@en
Tobramycin inhalation powder f ...... ew based on clinical evidence.
@nl
prefLabel
Tobramycin inhalation powder f ...... ew based on clinical evidence.
@en
Tobramycin inhalation powder f ...... ew based on clinical evidence.
@nl
P2860
P921
P356
P1476
Tobramycin inhalation powder f ...... ew based on clinical evidence.
@en
P2093
Kamal Hamed
Laurie Debonnett
P2860
P304
P356
10.1177/1753465817691239
P5008
P577
2017-02-17T00:00:00Z
2017-05-01T00:00:00Z